Related Experiment Videos
Myelomeningocele newborn management: time for parental decision
Insights
Parents of newborns with myelomeningocele (spina bifida) do not need to rush surgical decisions. Study shows no difference in outcomes whether surgery is immediate or delayed, allowing for informed parental consent.
Area of Science:
- Pediatric Surgery
- Neonatal Care
- Neuroscience
Background:
- Myelomeningocele is a severe birth defect requiring surgical intervention.
- Timely surgical management is often considered critical for neonatal outcomes.
- Parental involvement in decision-making for congenital anomalies is increasingly important.
Purpose of the Study:
- To evaluate the impact of delayed surgical intervention on neonatal outcomes in myelomeningocele.
- To determine if immediate surgery is essential for managing newborns with myelomeningocele.
- To assess the feasibility of providing parents more time for informed consent regarding myelomeningocele management.
Main Methods:
- Retrospective review of 110 newborn referrals with myelomeningocele.
- Categorization of surgical timing: early (<48 hours), delayed (3-7 days), late (>7 days).
- Analysis of mortality and morbidity (paralysis, ventriculitis, developmental delay) across surgical groups.
Main Results:
- 47% had early surgery, 29% delayed, 11% late, and 13% no surgery.
- No significant differences in mortality at 10 months (92-100% survival) among surgical groups.
- Comparable rates of worsening paralysis, ventriculitis, and developmental delay across early, delayed, and late surgery cohorts.
Conclusions:
- Urgency for initial surgical intervention in neonatal myelomeningocele is not supported by current data.
- Delayed surgical management allows for comprehensive parental counseling and informed consent.
- Flexible surgical timing can be considered in the initial management of myelomeningocele without compromising patient outcomes.
Abstract:
We retrospectively reviewed a process whereby parents were afforded additional time to decide the initial managements of their newborn with myelomeningocele. Of 110 newborn referrals, 52 (47%) had early surgery within the first 48 hours, 32 (29%) had delayed surgery between 3-7 days, 12 (11%) had late surgery from 7 days to 10 months, and 14 (13%) had no surgery, per parental request. There were no significant differences among the early, delayed or late surgery groups in mortality where 92%, 94% and 100% respectively were alive at 10 months, or the morbidity of worsening paralysis, ventriculitis or developmental delay. Our data suggest, therefore that there is no urgency or emergency for surgical intervention in the initial management of newborns with myelomeningocele. Rather, there is time to fully discuss issues with parents and obtain a better-informed consent for or against surgical management.